AdaptHealth
AHCO
172 hedge funds and large institutions have $1.38B invested in AdaptHealth in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 64 reducing their positions, and 41 closing their positions.
513% more call options, than puts
Call options by funds: $18.2M | Put options by funds: $2.97M
3.32% more ownership
Funds ownership: 78.84% → 82.17% (+3.3%)
0% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 64
11% less funds holding
Funds holding: 193 → 172 (-21)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
32% less capital invested
Capital invested by funds: $2.04B → $1.38B (-$660M)
46% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$54.6M |
| 2 |
Jane Street
New York
|
+$27.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$14.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.6M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
-$18.8M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$8.39M |
| 3 |
Millennium Management
New York
|
-$7M |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$4.07M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$3.73M |
AHCO Hedge Fund Activity: Q1 2023 in Review
172 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q1 2023, worth a combined $1.38B — down 32% from $2.04B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of AHCO and 22 opened new positions — a net loss of 19 holders — while 64 trimmed existing stakes and 64 added.
The largest buyer was Deerfield Management, adding an estimated $54.6M. The largest seller was Amundi, exiting entirely with an estimated $18.8M sold.
- 172 institutional investors held AdaptHealth (AHCO) as of Q1 2023, down from 193 in Q4 2022.
- Funds reported $1.38B of AdaptHealth stock for Q1 2023, down 32% quarter-over-quarter.
- 22 funds opened new AdaptHealth positions in Q1 2023 and 41 closed out, a net change of -19 holders.
- The largest AdaptHealth buyer in Q1 2023 was Deerfield Management, an estimated $54.6M added.
- The largest AdaptHealth seller in Q1 2023 was Amundi, an estimated $18.8M sold.
Based on aggregated 13F filings for Q1 2023.